These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12171002)

  • 1. Superinfection (reinfection): new study in San Francisco offers free resistance and viral load testing.
    James JS
    AIDS Treat News; 2000 Dec; (356):3-4. PubMed ID: 12171002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug induced superinfection in HIV and the evolution of drug resistance.
    Leontiev VV; Maury WJ; Hadany L
    Infect Genet Evol; 2008 Jan; 8(1):40-50. PubMed ID: 18024234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the unpredictable: transmission of drug-resistant HIV.
    Blower SM; Aschenbach AN; Gershengorn HB; Kahn JO
    Nat Med; 2001 Sep; 7(9):1016-20. PubMed ID: 11533704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 superinfection in an HIV-2-infected woman with subsequent control of HIV-1 plasma viremia.
    Günthard HF; Huber M; Kuster H; Shah C; Schüpbach J; Trkola A; Böni J
    Clin Infect Dis; 2009 Jun; 48(11):e117-20. PubMed ID: 19382874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barebacking no more: transmission of resistant HIV strains a reality.
    Arroyo H
    Newsline People AIDS Coalit N Y; 1998 Sep; ():18-9. PubMed ID: 11367484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. San Francisco: viral load trial offers free tests.
    AIDS Treat News; 1995 Sep; (no 230):7. PubMed ID: 11362762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 group M superinfection in an HIV-1 group O-infected patient.
    Plantier JC; Lemée V; Dorval I; Gueudin M; Braun J; Hutin P; Ruffault A; Simon F
    AIDS; 2004 Dec; 18(18):2444-6. PubMed ID: 15622327
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of drug resistance on viral load in patients failing antiretroviral therapy.
    Machouf N; Thomas R; Nguyen VK; Trottier B; Boulassel MR; Wainberg MA; Routy JP
    J Med Virol; 2006 May; 78(5):608-13. PubMed ID: 16555280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recovery of viremic control after superinfection with pathogenic HIV type 1 in a long-term elite controller of HIV type 1 infection.
    Rachinger A; Navis M; van Assen S; Groeneveld PH; Schuitemaker H
    Clin Infect Dis; 2008 Dec; 47(11):e86-9. PubMed ID: 18947331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of drug resistance mutations in plasma and peripheral blood mononuclear cells at different plasma viral loads in patients receiving HAART.
    Chew CB; Potter SJ; Wang B; Wang YM; Shaw CO; Dwyer DE; Saksena NK
    J Clin Virol; 2005 Jul; 33(3):206-16. PubMed ID: 15911442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of resistance testing.
    Albrecht H
    AIDS Clin Care; 2002 May; 14(5):46. PubMed ID: 12004878
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment benefit on cerebrospinal fluid HIV-1 levels in the setting of systemic virological suppression and failure.
    Spudich S; Lollo N; Liegler T; Deeks SG; Price RW
    J Infect Dis; 2006 Dec; 194(12):1686-96. PubMed ID: 17109340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of drug resistance mutations as a predictor of subsequent virological failure in patients with HIV-1 viral rebounds of less than 1,000 RNA copies/ml.
    Verhofstede C; Van Wanzeele F; Van Der Gucht B; Pelgrom J; Vandekerckhove L; Plum J; Vogelaers D
    J Med Virol; 2007 Sep; 79(9):1254-60. PubMed ID: 17607772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study: no superinfection among high-risk couples.
    AIDS Policy Law; 2004 Aug; 19(15):1. PubMed ID: 15366108
    [No Abstract]   [Full Text] [Related]  

  • 15. Multidrug-resistant HIV-1.
    Tayloe D
    Clin Infect Dis; 2004 May; 38(10):1507; author reply 1507. PubMed ID: 15156500
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeks.
    Paton NI; Aboulhab J
    HIV Med; 2005 Jan; 6(1):13-20. PubMed ID: 15670247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-class-resistant human immunodeficiency virus type 1 variant in a drug-naive heterosexual couple.
    Razzolini F; Saladini F; Malincarne L; Vicenti I; Palladino N; Romano L; Francisci D; Zazzi M
    J Clin Microbiol; 2008 Nov; 46(11):3856-9. PubMed ID: 18845824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on factors associated with heterosexual-transmission of human immunodeficiency virus in central China].
    Li L; Li JY; Bao ZY; Liu SY; Zhuang DM; Liu YJ; Feng FM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):980-3. PubMed ID: 14687496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
    Bassetti D; Cargnel A
    Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.
    Delaugerre C; Warszawski J; Chaix ML; Veber F; Macassa E; Buseyne F; Rouzioux C; Blanche S
    J Med Virol; 2007 Sep; 79(9):1261-9. PubMed ID: 17607781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.